Mr. Adam Fine is a Co-Founder and serves as Chief Executive Officer, Managing Director and General Partner at Windham Venture Partners. He also serves as Board Member at Neuspera and CredSimple. He is a Board Observer of BehaveCare. He served as Board Member at Coravin. He served as Board Observed at SpineView and CuraSeal. He serves as Director at GlySens and HelpAround, Board Observer to MC10, Holaira and VytronUS. He is a mentor in Blueprint Health, a healthcare IT accelerator in NYC. Prior to Windham, he was Vice President and General Manager at I-many, Inc., an enterprise software company. Prior to joining I-many, he was a New Business Development Analyst at Cordis Corporation, a Johnson & Johnson company focused on interventional vascular devices such as stents. In that capacity, he worked on a range of licenses, acquisitions, divestments, as well as strategic investments with Johnson & Johnson Development Corporation (JJDC), J&J's strategic venture arm. Prior to J&J, he was a research analyst at Coopers & Lybrand's Integrated Healthcare Consulting practice. He received his BA and graduated cum laude with distinction from Boston University and received his MBA from New York University.